Congress Wealth Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$31.1M Buy
289,421
+48,132
+20% +$4.87M 0.3% 77
2025
Q1
$24.3M Buy
241,289
+5,902
+3% +$594K 0.29% 85
2024
Q4
$21M Buy
235,387
+13,293
+6% +$1.17M 0.29% 91
2024
Q3
$18.6M Buy
222,094
+4,759
+2% +$375K 0.25% 109
2024
Q2
$16.7M Buy
217,335
+15,045
+7% +$1.1M 0.27% 99
2024
Q1
$13.9M Sell
202,290
-6,509
-3% -$419K 0.24% 126
2023
Q4
$12.1M Buy
208,799
+14,004
+7% +$748K 0.22% 133
2023
Q3
$10.3M Buy
+194,795
New +$10.2M 0.21% 140
2023
Q2
– Sell
-11,330
Closed -$567K – 558
2023
Q1
$567K Buy
11,330
+314
+3% +$14.8K 0.01% 403
2022
Q4
$510K Sell
11,016
-540
-5% -$23.4K 0.01% 405
2022
Q3
$447K Buy
11,556
+110
+1% +$4.41K 0.01% 423
2022
Q2
$427K Buy
+11,446
New +$466K 0.01% 427

Other funds holding BSX

Congress Wealth Management's BSX Position: Q2 2025 in Review

Congress Wealth Management increased its Boston Scientific (BSX) stake by 20% in Q2 2025, buying an estimated $4.87M and bringing the position to 289,421 shares worth $31.1M. The position accounts for 0.3% of the portfolio, ranked #77.

Congress Wealth Management first reported a position in BSX in Q2 2022 and has held it in 12 quarters since. 1,693 funds tracked by Wall St. Rank hold BSX as of Q2 2025.

  • Congress Wealth Management held 289,421 shares of Boston Scientific worth $31.1M as of Q2 2025.
  • Congress Wealth Management bought 48,132 Boston Scientific shares in Q2 2025, an estimated $4.87M.
  • Boston Scientific made up 0.3% of Congress Wealth Management's portfolio in Q2 2025, its #77 holding.
  • Congress Wealth Management first reported a position in Boston Scientific in Q2 2022 and has held it in 12 quarters since.
  • 1,693 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2025.

Based on Congress Wealth Management's 13F filing for Q2 2025, filed 13 Aug 2025.